作者
Mary Wu, Edward Carr, Ruth Harvey, Joshua Gahir, Hermaleigh Townsley, Guilia Dowgier, Agnieska Hobbs, Lou Herman, Martina Ragno, Murad Miah, Philip Bawumia, Callie Smith, Mauro Miranda, Harriet Mears, Lorin Adams, Emine Haptioglu, Nicola O'Reilly, Scott Warchal, Chelsea Sawyer, Karen Ambrose, Gavin Kelly, Rupert Beale, Padmasayee Papineni, Tumena Corrah, Richard Gilson, Steve Gamblin, George Kassiotis, Vincenzo Libri, Bryan Williams, Charles Swanton, Sonia Gandhi, David Bauer, Emma Wall
发表日期
2023/12/1
期刊
Clinical Infection in Practice
卷号
20
页码范围
100260
出版商
Elsevier
简介
Background
As the COVID-19 pandemic continues globally, new variants-of-concern (VOCs) emerge, including XBB and BQ. 1.1. These Omicron sub-lineage viruses, have potential for immune evasion and thus consequences for vulnerable patients and healthcare provision.
Methods
We use high-throughput live-virus microneutralisation assays to study the serological responses against VOCs including XBB and BQ. 1.1 before and after 4th dose bivalent (BNT162b2+ BA1 or mRNA1273. 214) vaccination in 174 healthy adults.
学术搜索中的文章
M Wu, E Carr, R Harvey, J Gahir, H Townsley… - Clinical Infection in Practice, 2023